Nantong Jinghua Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 969.01 million compared to CNY 925.64 million a year ago. Revenue was CNY 969.01 million compared to CNY 925.64 million a year ago. Net income was CNY 128.4 million compared to CNY 101.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.1577 compared to CNY 0.1249 a year ago. Diluted earnings per share from continuing operations was CNY 0.1577 compared to CNY 0.1249 a year ago.